Feb 26, 2026 06:00AM
Jan 6, 2026 01:31PM
Jan 6, 2026 01:30PM
Dec 18, 2025 06:00AM
Dec 18, 2025 06:00AM
Dec 8, 2025 08:00AM
Dec 7, 2025 06:00PM Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
Nov 26, 2025 06:00AM
Nov 26, 2025 06:00AM
Nov 20, 2025 06:00AM
Nov 6, 2025 06:00AM
Oct 13, 2025 06:00AM
Oct 13, 2025 06:00AM
Sep 29, 2025 08:30AM Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
Sep 11, 2025 08:18AM
Aug 29, 2025 06:00AM
Aug 29, 2025 06:00AM
Aug 11, 2025 04:56PM
Aug 11, 2025 04:55PM
Aug 8, 2025 09:05AM
Aug 8, 2025 09:00AM Oncolytics Biotech to delist from Toronto Stock Exchange on August 22
Aug 8, 2025 09:00AM
Aug 6, 2025 06:00AM
Aug 5, 2025 08:30AM
Jul 31, 2025 06:01AM
Jul 31, 2025 06:00AM
Jul 29, 2025 08:30AM
Jul 29, 2025 08:30AM Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End
Jul 23, 2025 09:39AM
Jul 22, 2025 03:33PM
Jul 22, 2025 03:32PM
Jul 16, 2025 08:30AM
Jul 10, 2025 08:30AM
Jul 8, 2025 08:30AM
Jun 30, 2025 07:00AM Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
Jun 25, 2025 06:01AM
Jun 25, 2025 06:00AM
Jun 12, 2025 06:00AM
Jun 11, 2025 04:05PM
Jun 11, 2025 04:05PM
Jun 11, 2025 07:00AM
May 31, 2025 08:00AM BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025
May 23, 2025 07:00AM
May 14, 2025 04:05PM
May 14, 2025 04:01PM
May 7, 2025 06:00AM
May 6, 2025 07:00AM
Apr 24, 2025 07:00AM
Apr 10, 2025 06:09PM Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital
Apr 10, 2025 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All